Document
IPR2024-00631, No. 1025 Exhibit - 1025 Glaesner, Engineering and Characterization of the Long Acting Glucagon (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1025 Exhibit - 1025 Glaesner, Engineering and Characterization of the Long Acting Glucagon (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1076 Exhibit - 1076 ClinicalTrialsgov Background, CLINICALTRIALSGOV, httpsclinicaltri (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1076 Exhibit - 1076 ClinicalTrialsgov Background, CLINICALTRIALSGOV, httpsclinicaltri (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1052 Exhibit - 1052 Madsbad, An Overview of Once Weekly Glucagon Like Peptide 1 Receptor A (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1052 Exhibit - 1052 Madsbad, An Overview of Once Weekly Glucagon Like Peptide 1 Receptor A (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1064 Exhibit - 1064 Monami, Effects of Glucagon Like Peptide 1 Receptor Agonists on Body W (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1064 Exhibit - 1064 Monami, Effects of Glucagon Like Peptide 1 Receptor Agonists on Body W (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1047 Exhibit - 1047 Tamimi, Drug Development From Concept to Marketing, 113 NEPHRON CLIN (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1047 Exhibit - 1047 Tamimi, Drug Development From Concept to Marketing, 113 NEPHRON CLIN (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1054 Exhibit - 1054 Landersdorfer, Mechanism Based Population Pharmacokinetic Modelling in (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1054 Exhibit - 1054 Landersdorfer, Mechanism Based Population Pharmacokinetic Modelling in (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1018 Exhibit - 1018 Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL ME (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1018 Exhibit - 1018 Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL ME (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1063 Exhibit - 1063 Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What M (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1063 Exhibit - 1063 Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What M (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1041 Exhibit - 1041 WO 03002136 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1041 Exhibit - 1041 WO 03002136 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1021 Exhibit - 1021 Byetta prescribing information Oct 2009 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1021 Exhibit - 1021 Byetta prescribing information Oct 2009 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1002 Exhibit - 1002 Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1002 Exhibit - 1002 Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1066 Exhibit - 1066 Knudsen, Liraglutide The Therapeutic Promise from Animal Models, 64s (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1066 Exhibit - 1066 Knudsen, Liraglutide The Therapeutic Promise from Animal Models, 64s (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1065 Exhibit - 1065 Tasneem, The Database for Aggregate Analysis of ClinicalTrialsgov AA (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1065 Exhibit - 1065 Tasneem, The Database for Aggregate Analysis of ClinicalTrialsgov AA (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1060 Exhibit - 1060 WO 2011058193 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1060 Exhibit - 1060 WO 2011058193 (P.T.A.B. Mar. 1, 2024)
+ More Snippets